Free Trial

CervoMed (CRVO) News Today

CervoMed logo
$1.94 -0.01 (-0.51%)
(As of 12/17/2024 ET)
CervoMed downgraded to Neutral from Buy at H.C. Wainwright
HC Wainwright & Co. Downgrades CervoMed (CRVO)
CervoMed (CRVO) was downgraded to a Hold Rating at H.C. Wainwright
What is Roth Capital's Estimate for CervoMed Q1 Earnings?
CervoMed announces inducement grants under Nasdaq lisitng rule
CervoMed price target lowered to $12 from $65 at Canaccord
CervoMed (NASDAQ:CRVO) Earns "Hold" Rating from D. Boral Capital
Morgan Stanley downgrades CervoMed (CRVO) to a Sell
Chardan Capital Downgrades CervoMed (CRVO)
Jones Trading Downgrades CervoMed (CRVO)
D. Boral Capital Downgrades CervoMed (CRVO)
CervoMed Faces Setback in Phase 2b Trial
HC Wainwright Estimates CervoMed FY2024 Earnings
CervoMed (NASDAQ:CRVO) Earns Buy Rating from Analysts at Roth Mkm
CervoMed Inc. stock logo
HC Wainwright Forecasts CervoMed FY2024 Earnings
CervoMed Inc. (NASDAQ:CRVO - Free Report) - Equities research analysts at HC Wainwright issued their FY2024 EPS estimates for CervoMed in a research report issued on Thursday, December 5th. HC Wainwright analyst R. Selvaraju expects that the company will post earnings per share of ($1.76) for the
What is HC Wainwright's Forecast for CervoMed Q4 Earnings?
CervoMed Inc. stock logo
CervoMed (NASDAQ:CRVO) Coverage Initiated by Analysts at Roth Mkm
Roth Mkm began coverage on shares of CervoMed in a research report on Friday. They set a "buy" rating and a $45.00 target price on the stock.
CervoMed Inc. stock logo
Q4 Earnings Forecast for CervoMed Issued By HC Wainwright
CervoMed Inc. (NASDAQ:CRVO - Free Report) - Stock analysts at HC Wainwright issued their Q4 2024 earnings per share estimates for CervoMed in a research report issued on Thursday, December 5th. HC Wainwright analyst R. Selvaraju anticipates that the company will post earnings per share of ($0.53)
CervoMed Enhances Transparency with Key Information Access
CervoMed Inc. stock logo
CervoMed's (CRVO) Buy Rating Reaffirmed at D. Boral Capital
D. Boral Capital reiterated a "buy" rating and issued a $34.00 target price on shares of CervoMed in a research note on Wednesday.
CervoMed initiated with a Buy at D. Boral Capital
CervoMed Inc. stock logo
CervoMed Inc. (NASDAQ:CRVO) Short Interest Up 16.5% in October
CervoMed Inc. (NASDAQ:CRVO - Get Free Report) was the target of a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 1,480,000 shares, an increase of 16.5% from the October 15th total of 1,270,000 shares. Based on an average daily volume of 81,400 shares, the days-to-cover ratio is presently 18.2 days. Currently, 27.7% of the shares of the stock are sold short.
CervoMed Inc. stock logo
Analysts Issue Forecasts for CervoMed FY2024 Earnings
CervoMed Inc. (NASDAQ:CRVO - Free Report) - Analysts at Brookline Capital Management dropped their FY2024 EPS estimates for CervoMed in a research report issued on Tuesday, November 12th. Brookline Capital Management analyst T. Bussian now expects that the company will post earnings of ($1.88) pe
CervoMed Inc. Reports Increased R&D Expenses Amid Ongoing Trials
CervoMed to Participate in Upcoming Investor Conferences
CervoMed announces key takeaways from presentations on neflamapimod
CervoMed Inc. stock logo
CervoMed Inc. (NASDAQ:CRVO) Short Interest Update
CervoMed Inc. (NASDAQ:CRVO - Get Free Report) was the recipient of a large growth in short interest in October. As of October 15th, there was short interest totalling 1,270,000 shares, a growth of 7.6% from the September 30th total of 1,180,000 shares. Approximately 23.7% of the company's stock are sold short. Based on an average trading volume of 86,700 shares, the short-interest ratio is presently 14.6 days.
CervoMed Inc. stock logo
CervoMed (NASDAQ:CRVO) Shares Down 3.1% - Time to Sell?
CervoMed (NASDAQ:CRVO) Shares Down 3.1% - Here's What Happened
CervoMed to present at International Lewy Body Dementia Conference
CervoMed Inc. (CRVO)
Get CervoMed News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRVO and its competitors with MarketBeat's FREE daily newsletter.

Trump’s Secret Manhattan Project (Ad)

On January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just spent six months investigating this...and what I found is shocking.

Click here and I’ll show you exactly how to position your money

CRVO Media Mentions By Week

CRVO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CRVO
News Sentiment

0.06

0.69

Average
Medical
News Sentiment

CRVO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CRVO Articles
This Week

21

2

CRVO Articles
Average Week

Get CervoMed News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRVO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:CRVO) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners